Search results for: Economics of Innovation

OHE Innovation Policy Prize

18 May 2022

…ultimately improving health and health care. A major area of research for OHE has always been the economics of innovation, and OHE has made significant contributions to the development of…

OHE Lunchtime Seminar: The People’s Prescription – Re-imagining Health Innovation to Deliver Public Value

27 September 2018, 11:00pm

…the rules of corporate governance. Mariana Mazzucato (PhD) is Professor in the Economics of Innovation and Public Value at University College London (UCL), and is Founder and Director of the…

What is the future of health economics?

1 May 2023

…McGuire, Professor of Health Economics at The London School of Economics and Political Science For Alistair McGuire, Professor of Health Economics at The London School of Economics and Political Science,…

Does Government Funding Increase Public Sector Development of New Medicines?

5 March 2021

…related publications on our research theme The Economics of Innovation listed below. Kourouklis, D., 2021. Public subsidies for R&D and public sector pharmaceutical innovation. Applied Economics, pp.1–19. 10.1080/00036846.2021.1885614. IFPMA., 2017….

How Does Pharmaceutical Spending Drive Innovation in Europe?

7 February 2022

…J., Sussex, J. and Towse, A., 2012. The R&D Cost of a New Medicine. [online] Office of Health Econom-ics. Available at: https://ideas.repec.org/b/ohe/monogr/000135.html [Accessed 27 Feb. 2021]. Towse, A. and Sharma,…

OHE Innovation Policy Prize

About the Innovation Policy Prize The economics of innovation has always been a leading research theme at OHE, and we are proud to have made significant contributions to the development of theory, evidence, and practice…

Innovation for Health System Efficiency and Improvement

20 November 2023

…outcomes We proposed a taxonomy of nine barriers that can prevent the adoption of innovative health technologies in health systems. The barriers relate to 1) intrinsic properties of the innovation…

Pharmaceutical Research: the Case for Growth in Britain

1 July 1967

…in this field, which is undertaken by the pharmaceutical industry in their development of new medicines, also has a good record, in terms both of innovation and of its earnings…

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

22 June 2022

Since the Office of Health Economics (OHE) published a critique of CBO’s new simulation model of new drug development late last year, the U.S. public sector think tank has made…